Science Explorer Back to mapMap
Discussion
Company · Malvern · United States

TetraLogic Pharmaceuticals (United States)

World rank, all time
#28,588
of 34,923
Rank in United States
#6,004
of 7,310
Research works
154
▲ 158% vs 2018-21
Citations
4.2k
27.0 per fractional work
Top-10% rate
9.5%
all institutions 10.0%
vs its own fields
0.95×
1.00× is exactly expected
Open access
44%
world 40%
International
24%
world 18%
TetraLogic Pharmaceuticals (United States)

Which fields of science does TetraLogic Pharmaceuticals (United States) work in?

In 2022-now, 49% of research at TetraLogic Pharmaceuticals (United States) is in Health Sciences, 18% in Physical Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (12%), Mathematics (9%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 24 fractional works · 48.7% of its workMedicine: 22 fractional works · 45.0% of its workPsychiatry and Mental health: 6 fractional works · 11.7% of its workPhysiology: 5 fractional works · 10.8% of its workNeurology: 3 fractional works · 6.1% of its workPharmacology: 2 fractional works · 3.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.7% of its workFamily Practice: 0 fractional works · 1.0% of its workEpidemiology: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.9% of its workHealth Informatics: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.8% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.7% of its workOncology: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.2% of its workGeriatrics and Gerontology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 2 fractional works · 3.5% of its workGeneral Health Professions: 2 fractional works · 3.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.1% of its workPhysical Sciences: 9 fractional works · 18.3% of its workMathematics: 4 fractional works · 9.1% of its workStatistics and Probability: 4 fractional works · 9.1% of its workComputer Science: 3 fractional works · 6.9% of its workComputational Theory and Mathematics: 2 fractional works · 4.5% of its workArtificial Intelligence: 1 fractional works · 2.4% of its workEnvironmental Science: 1 fractional works · 1.1% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workEngineering: 0 fractional works · 0.7% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workBuilding and Construction: 0 fractional works · 0.2% of its workMechanical Engineering: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.3% of its workBiomaterials: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workLife Sciences: 9 fractional works · 17.9% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 11.7% of its workMolecular Biology: 5 fractional works · 10.3% of its workAging: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.3% of its workBiotechnology: 0 fractional works · 0.2% of its workClinical Biochemistry: 0 fractional works · 0.2% of its workGenetics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 2 fractional works · 3.7% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.2% of its workCognitive Neuroscience: 1 fractional works · 1.2% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.7% of its workPharmacology: 0 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.7% of its workMicrobiology: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 15.1% of its workEconomics, Econometrics and Finance: 4 fractional works · 8.9% of its workEconomics and Econometrics: 4 fractional works · 8.9% of its workPsychology: 1 fractional works · 2.9% of its workClinical Psychology: 1 fractional works · 1.9% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.0% of its workSocial Sciences: 1 fractional works · 1.6% of its workSociology and Political Science: 0 fractional works · 0.8% of its workGender Studies: 0 fractional works · 0.5% of its workSafety Research: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 1.0% of its workStatistics, Probability and Uncertainty: 0 fractional works · 1.0% of its workArts and Humanities: 0 fractional works · 0.7% of its workPhilosophy: 0 fractional works · 0.7% of its workALL ITS WORKTetraLogicPharmaceuticals…49fractional works, 2022-now
Life Sciences18%Physical Sciences18%Health Sciences49%Social Sciences15%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine2245.0%
    2. Health Professions23.5%
    3. Dentistry00.1%
    1. Mathematics49.1%
    2. Computer Science36.9%
    3. Environmental Science11.1%
    4. Engineering00.7%
    5. Materials Science00.3%
    6. Chemistry00.3%
    1. Biochemistry, Genetics and Molecular Biology611.7%
    2. Neuroscience23.7%
    3. Pharmacology, Toxicology and Pharmaceutics11.7%
    4. Immunology and Microbiology00.9%
    1. Economics, Econometrics and Finance48.9%
    2. Psychology12.9%
    3. Social Sciences11.6%
    4. Decision Sciences01.0%
    5. Arts and Humanities00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.19× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 0.89× its world share, 0 worksImmunology and Micro…Neuroscience: 2.26× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.79× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.19× its world share, 0 worksChemistryComputer Science: 0.88× its world share, 3 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials ScienceMathematics: 7.70× its world share, 4 worksMathematicsDentistry: 0.28× its world share, 0 worksDentistryHealth Professions: 1.33× its world share, 2 worksHealth ProfessionsMedicine: 2.34× its world share, 22 worksMedicineArts and Humanities: 0.23× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.99× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 4.18× its world share, 4 worksEconomics, Econometr…Psychology: 0.94× its world share, 1 worksPsychologySocial Sciences: 0.13× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 7.7×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Mathematics7.70×4 works
  2. Pharmacology, Toxicology and Pharmaceutics4.79×1 works
  3. Economics, Econometrics and Finance4.18×4 works
  4. Medicine2.34×22 works
  5. Neuroscience2.26×2 works
  6. Biochemistry, Genetics and Molecular Biology2.19×6 works
  7. Health Professions1.33×2 works
  8. Decision Sciences0.99×0 works
  9. Psychology0.94×1 works
  10. Immunology and Microbiology0.89×0 works
  11. Computer Science0.88×3 works
  12. Dentistry0.28×0 works
  13. Arts and Humanities0.23×0 works
  14. Environmental Science0.22×0 works
  15. Chemistry0.19×0 works
  16. Social Sciences0.13×1 works
  17. Materials Science0.09×0 works
  18. Engineering0.05×0 works

Who are the top researchers at TetraLogic Pharmaceuticals (United States)?

Ranked on the quality score, Srinivas K. Chunduru, Suzanne B. Hendrix and Mark A. McKinlay lead among researchers whose main affiliation is TetraLogic Pharmaceuticals (United States).

  1. 1 Srinivas K. Chunduru United States · #496,792 worldwide 3.3k citations · 100 works
  2. 2 Suzanne B. Hendrix United States · #566,317 worldwide 5.9k citations · 275 works
  3. 3 Mark A. McKinlay United States · #602,424 worldwide 4.3k citations · 95 works
  4. 4 Christopher A. Benetatos United States · #823,144 worldwide 3k citations · 51 works
  5. 5 Samuel P. Dickson United States · #845,145 worldwide 2.6k citations · 81 works
  6. 6 Stephen M. Condon United States · #866,915 worldwide 3.8k citations · 83 works
  7. 7 Jessie Nicodemus‐Johnson United States · #1,338,983 worldwide 946 citations · 42 works
  8. 8 Martin A. Graham United States · #1,465,082 worldwide 865 citations · 39 works
  9. 9 Guangyao Yu United States · #1,987,320 worldwide 804 citations · 27 works
  10. 10 Noel Ellison United States · #2,190,929 worldwide 1.1k citations · 41 works
All ranked researchers at TetraLogic Pharmaceuticals (United States)

What are the most cited papers from TetraLogic Pharmaceuticals (United States)?

The most cited paper from TetraLogic Pharmaceuticals (United States) is "IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis" (James Edward Vince, Wendy Wei-Lynn Wong, Nufail R. Khan et al., 2007), with 1,071 citations. Next come "Reproducibility in Science" (1,070) and "RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL" (655).

Most cited papers
#PaperReleasedCitations
1 IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis James Edward Vince, Wendy Wei-Lynn Wong, Nufail R. Khan et al. · Cell Open access Nov 2007 1,071
2 Reproducibility in Science C. Glenn Begley, John P. A. Ioannidis · Circulation Research 31 Dec 2014 1,070
3 RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL Kate E. Lawlor, Nufail R. Khan, Alison Mildenhall et al. · Nature Communications Open access 18 Feb 2015 655
4 Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis Sabrina Paganoni et al. · New England Journal of Medicine Open access 2 Sep 2020 542
5 A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations William Edward Highsmith, Lauranell H. Burch, Zhaoqing Zhou et al. · New England Journal of Medicine Open access 13 Oct 1994 443
All 60 most cited papers, with filters and sorting

Which keywords describe research at TetraLogic Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Alzheimer's Disease, Biomarkers, Oxidative Stress, Neurodegeneration, Aging, Neuroimaging, Cognitive Training and Dementia.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Alzheimer's Disease10▲ 72×6 topics
  2. Biomarkers8▲ 24×6 topics
  3. Oxidative Stress8▲ 9.4×11 topics
  4. Neurodegeneration7▲ 49×5 topics
  5. Aging6▲ 24×7 topics
  6. Cognitive Training6▲ 121×2 topics
  7. Dementia6▲ 118×1 topic
  8. Mild Cognitive Impairment6▲ 132×1 topic
  9. Neuroimaging6▲ 41×4 topics
  10. Neuroinflammation5▲ 37×2 topics
  11. Amyloid Hypothesis5▲ 175×1 topic
  12. Tau Pathology5▲ 175×1 topic
  13. Quality of Life5▲ 6.6×5 topics
  14. Cost-effectiveness Analysis4▲ 96×1 topic
  15. Health Utility Measures4▲ 96×1 topic
  16. Machine Learning3▲ 1.93×4 topics
  17. Mitochondrial Dysfunction3▲ 20×5 topics
  18. Metabolic Syndrome3▲ 7.0×4 topics
  19. Cancer3▲ 4.0×2 topics
  20. Phosphoethanolamine3▲ 393×1 topic
  21. Synthetic3▲ 393×1 topic
  22. Medicinal Chemistry2▲ 17×2 topics
  23. Bayesian Methods2▲ 88×2 topics
  24. Molecular Docking2▲ 37×1 topic
  25. Parkinson's Disease2▲ 18×4 topics
  26. Virtual Screening2▲ 50×1 topic
  27. Adaptive Designs2▲ 201×1 topic
  28. False Discovery Rate2▲ 201×1 topic
  29. Causal Inference2▲ 102×1 topic
  30. Diagnostic Criteria2▲ 16×2 topics
  31. Neurodegenerative Diseases2▲ 23×3 topics
  32. Propensity Score2▲ 178×1 topic
  33. Toxicology2▲ 20×2 topics
  34. Dopaminergic Neurons2▲ 52×1 topic
  35. a-Synuclein2▲ 64×1 topic
  36. Acetylcholinesterase2▲ 146×1 topic
  37. Cholinesterase Inhibitors2▲ 146×1 topic
  38. Clinical Trials2▲ 4.5×4 topics
  39. Community Engagement1▲ 7.3×2 topics
  40. Neurological Disorders1▲ 3.7×6 topics

Which research topics does TetraLogic Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Health Systems, Economic Evaluations, Quality of Life and Biological Research and Disease Studies.

  1. 1 Dementia and Cognitive Impairment Research Psychiatry and Mental health 6 works
  2. 2 Alzheimer's disease research and treatments Physiology 5 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  4. 4 Biological Research and Disease Studies Molecular Biology 3 works
  5. 5 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
  6. 6 Statistical Methods in Clinical Trials Statistics and Probability 2 works
  7. 7 Advanced Causal Inference Techniques Statistics and Probability 2 works
  8. 8 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
  9. 9 Cholinesterase and Neurodegenerative Diseases Pharmacology 2 works
  10. 10 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.1%not open55.9%

World: 40% of research is openly available.

with international co-authors24.1%domestic only75.9%

World: 18% is written across borders.

How has TetraLogic Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 158% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is TetraLogic Pharmaceuticals (United States) as a percentage of every work published that year, 0.00023% in 2024.

still counting0.00025%0.00050%0.00075%TetraLogic Pharmaceuticals (United States)0.00034% in 202519801990200020102020

Fractional works of TetraLogic Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Malvern

All research institutions in Malvern

Share TetraLogic Pharmaceuticals (United States)'s ranking

TetraLogic Pharmaceuticals (United States) on Science Explorer

A card with TetraLogic Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about TetraLogic Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.